Global Cancer Medication Market Growth, Trends, and Forecasts 2016-2026

August 2021 | 105 pages | ID: G4E3B0A45806EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to this latest study, the 2021 growth of Cancer Medication will have significant change from previous year. By the most conservative estimates of global Cancer Medication market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Cancer Medication market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Medication market by product type, application, key manufacturers and key regions and countries.

Segmentation by product type

• Antimetabolite
• Alkaloid Drugs
• Hormone
• Targeted Drug
• Platinum-based Drugs
• Other

Segmentation by Application

• Blood Cancer
• Breast Cancer
• Castrointestinal Cancer
• Prostate Cancer
• Respiratory/Lung Cancer
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• Rest of Americas
• APAC
• China
• Japan
• Korea
• Taiwan
• India
• Australia
• Indonesia
• Thailand
• Malaysia
• Philippines
• Vietnam
• Rest of APAC
• Europe
• Germany
• France
• UK
• Russia
• Italy
• Benelux
• Nordic
• Rest of Europe
• MENA
• Saudi Arabia
• UAE
• Turkey
• South Africa
• Egypt
• Rest of MENA

The report also presents the market competition landscape and a corresponding detailed analysis of the major companies in the market.

• Roche
• HENGRUI
• AstraZeneca
• QILU
• Sanofi
• HANSOH
• LUYE
• Novartis
• GuiZhou YiBai
• Lunan
• Eli Lilly and Company

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 Market Overview
  2.1.1 Global Cancer Medication Market Size and Forecast, 2016-2026
  2.1.2 Cancer Medication Market Size and Forecast by Region, 2016 VS 2021 VS 2026
2.2 Global Cancer Medication Market Size and Forecast by Regions, 2016-2026 ($ millions)
2.3 Americas Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
2.4 APAC Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
2.5 Europe Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
2.6 MENA Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)

3 CANCER MEDICATION MARKET SIZE BY PLAYER

3.1 Global Cancer Medication Market Size by Player
  3.1.1 Global Top Players Cancer Medication Revenue, 2019-2021E ($ millions)
  3.1.2 Global Top Cancer Medication Players Market Share, 2019-2021E
3.2 Global Key Cancer Medication Players Rank in 2020
3.3 Global Key Cancer Medication Players Head office and Products Offered
3.4 Market Concentration Rate Analysis
  3.4.1 Competition Landscape Analysis
  3.4.2 Concentration Ratio (CR3, CR5 and CR10), 2019-2021E
3.5 New Products and Potential Entrants
3.6 Mergers & Acquisitions, Expansion

4 CANCER MEDICATION SEGMENT BY TYPE

4.1 Overview
  4.1.1 Antimetabolite
  4.1.2 Alkaloid Drugs
  4.1.3 Hormone
  4.1.4 Targeted Drug
  4.1.5 Platinum-based Drugs
  4.1.6 Other
4.2 Global Cancer Medication Market Size by Type, 2016-2026 ($ millions)
4.3 Antimetabolite Market Size by Region, 2016-2026 ($ millions)
4.4 Alkaloid Drugs Market Size by Region, 2016-2026 ($ millions)
4.5 Hormone Market Size by Region, 2016-2026 ($ millions)
4.6 Targeted Drug Market Size by Region, 2016-2026 ($ millions)
4.7 Platinum-based Drugs Market Size by Region, 2016-2026 ($ millions)
4.8 Other Market Size by Region, 2016-2026 ($ millions)

5 CANCER MEDICATION SEGMENT BY APPLICATION

5.1 Overview
  5.1.1 Blood Cancer
  5.1.2 Breast Cancer
  5.1.3 Castrointestinal Cancer
  5.1.4 Prostate Cancer
  5.1.5 Respiratory/Lung Cancer
  5.1.6 Other
5.2 Global Cancer Medication Market Size and Forecast by Application, 2016-2026
5.3 Blood Cancer Market Size by Region, 2016-2026 ($ millions)
5.4 Breast Cancer Market Size by Region, 2016-2026 ($ millions)
5.5 Castrointestinal Cancer Market Size by Region, 2016-2026 ($ millions)
5.6 Prostate Cancer Market Size by Region, 2016-2026 ($ millions)
5.7 Respiratory/Lung Cancer Market Size by Region, 2016-2026 ($ millions)
5.8 Other Market Size by Region, 2016-2026 ($ millions)

6 AMERICAS

6.1 Americas Cancer Medication Market Size by Country
6.2 United States Cancer Medication Market Size
6.3 Canada Cancer Medication Market Size
6.4 Mexico Cancer Medication Market Size
6.5 Brazil Cancer Medication Market Size

7 APAC

7.1 APAC Cancer Medication Market Size by Region
7.2 China Cancer Medication Market Size
7.3 Japan Cancer Medication Market Size
7.4 Korea Cancer Medication Market Size
7.5 Taiwan Cancer Medication Market Size
7.6 India Cancer Medication Market Size
7.7 Australia Cancer Medication Market Size
7.8 Indonesia Cancer Medication Market Size
7.9 Thailand Cancer Medication Market Size
7.10 Malaysia Cancer Medication Market Size
7.11 Philippines Cancer Medication Market Size
7.12 Vietnam Cancer Medication Market Size

8 EUROPE

8.1 Europe Cancer Medication Market Size by Country
8.2 Germany Cancer Medication Market Size
8.3 France Cancer Medication Market Size
8.4 UK Cancer Medication Market Size
8.5 Russia Cancer Medication Market Size
8.6 Italy Cancer Medication Market Size
8.7 Australia Cancer Medication Market Size
8.8 Benelux Cancer Medication Market Size
8.9 Nordic Cancer Medication Market Size

9 MENA

9.1 MENA Cancer Medication Market Size by Country
9.2 Saudi Arabia Cancer Medication Market Size
9.3 UAE Cancer Medication Market Size
9.4 Turkey Cancer Medication Market Size
9.5 South Africa Cancer Medication Market Size
9.6 Egypt Cancer Medication Market Size

10 MARKET DRIVERS, CHALLENGES AND TRENDS

10.1 Market Drivers and Impact
  10.1.1 Growing Demand from Key Regions
  10.1.2 Growing Demand from Key Applications and Potential Industries
10.2 Market Challenges and Impact
10.3 Market Trends

11 KEY PLAYERS ANALYSIS

11.1 Roche
  11.1.1 Roche Company Information
  11.1.2 Roche Cancer Medication Product Offered
  11.1.3 Roche Cancer Medication Revenue and YoY Growth, 2019-2021E
  11.1.4 Roche Main Business Overview
  11.1.5 Roche Latest Developments
11.2 HENGRUI
  11.2.1 HENGRUI Company Information
  11.2.2 HENGRUI Cancer Medication Product Offered
  11.2.3 HENGRUI Cancer Medication Revenue and YoY Growth, 2019-2021E
  11.2.4 HENGRUI Main Business Overview
  11.2.5 HENGRUI Latest Developments
11.3 AstraZeneca
  11.3.1 AstraZeneca Company Information
  11.3.2 AstraZeneca Cancer Medication Product Offered
  11.3.3 AstraZeneca Cancer Medication Revenue and YoY Growth, 2019-2021E
  11.3.4 AstraZeneca Main Business Overview
  11.3.5 AstraZeneca Latest Developments
11.4 QILU
  11.4.1 QILU Company Information
  11.4.2 QILU Cancer Medication Product Offered
  11.4.3 QILU Cancer Medication Revenue and YoY Growth, 2019-2021E
  11.4.4 QILU Main Business Overview
  11.4.5 QILU Latest Developments
11.5 Sanofi
  11.5.1 Sanofi Company Information
  11.5.2 Sanofi Cancer Medication Product Offered
  11.5.3 Sanofi Cancer Medication Revenue and YoY Growth, 2019-2021E
  11.5.4 Sanofi Main Business Overview
  11.5.5 Sanofi Latest Developments
11.6 HANSOH
  11.6.1 HANSOH Company Information
  11.6.2 HANSOH Cancer Medication Product Offered
  11.6.3 HANSOH Cancer Medication Revenue and YoY Growth, 2019-2021E
  11.6.4 HANSOH Main Business Overview
  11.6.5 HANSOH Latest Developments
11.7 LUYE
  11.7.1 LUYE Company Information
  11.7.2 LUYE Cancer Medication Product Offered
  11.7.3 LUYE Cancer Medication Revenue and YoY Growth, 2019-2021E
  11.7.4 LUYE Main Business Overview
  11.7.5 LUYE Latest Developments
11.8 Novartis
  11.8.1 Novartis Company Information
  11.8.2 Novartis Cancer Medication Product Offered
  11.8.3 Novartis Cancer Medication Revenue and YoY Growth, 2019-2021E
  11.8.4 Novartis Main Business Overview
  11.8.5 Novartis Latest Developments
11.9 GuiZhou YiBai
  11.9.1 GuiZhou YiBai Company Information
  11.9.2 GuiZhou YiBai Cancer Medication Product Offered
  11.9.3 GuiZhou YiBai Cancer Medication Revenue and YoY Growth, 2019-2021E
  11.9.4 GuiZhou YiBai Main Business Overview
  11.9.5 GuiZhou YiBai Latest Developments
11.10 Lunan
  11.10.1 Lunan Company Information
  11.10.2 Lunan Cancer Medication Product Offered
  11.10.3 Lunan Cancer Medication Revenue and YoY Growth, 2019-2021E
  11.10.4 Lunan Main Business Overview
  11.10.5 Lunan Latest Developments
11.11 Eli Lilly and Company
  11.11.1 Eli Lilly and Company Company Information
  11.11.2 Eli Lilly and Company Cancer Medication Product Offered
  11.11.3 Eli Lilly and Company Cancer Medication Revenue and YoY Growth, 2019-2021E
  11.11.4 Eli Lilly and Company Main Business Overview
  11.11.5 Eli Lilly and Company Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Cancer Medication Market Size CAGR by Region 2020-2026 ($ Millions)
Table 2. Global Cancer Medication Market Size by Regions, 2016-2026 ($ millions)
Table 3. Global Cancer Medication Market Size Share by Regions, 2016-2026
Table 4. Global Cancer Medication Revenue by Player, 2019-2021E ($ millions)
Table 5. Global Cancer Medication Revenue Market Share by Player, 2019-2021E
Table 6. Global Key Cancer Medication Players Rank in 2020, Based on the Revenue in Cancer Medication
Table 7. Global Key Cancer Medication Players Head office and Products Offered
Table 8. Cancer Medication Concentration Ratio (CR3, CR5 and CR10), 2019-2021E
Table 9. New Products and Potential Entrants
Table 10. Mergers & Acquisitions, Expansion
Table 11. Major Players of Antimetabolite
Table 12. Major Players of Alkaloid Drugs
Table 13. Major Players of Hormone
Table 14. Major Players of Targeted Drug
Table 15. Major Players of Platinum-based Drugs
Table 16. Major Players of Other
Table 17. Global Cancer Medication Market Size CAGR by Type ($ millions): 2016 VS 2021 VS 2026
Table 18. Global Cancer Medication Market Size by Type, 2016-2026 ($ millions)
Table 19. Global Cancer Medication Market Size Share by Type, 2016-2026
Table 20. Global Antimetabolite Market Size by Region, 2016-2026 ($ millions)
Table 21. Global Antimetabolite Market Size Share by Region, 2016-2026
Table 22. Global Alkaloid Drugs Market Size by Region, 2016-2026 ($ millions)
Table 23. Global Alkaloid Drugs Market Size Share by Region, 2016-2026
Table 24. Global Hormone Market Size by Region, 2016-2026 ($ millions)
Table 25. Global Hormone Market Size Share by Region, 2016-2026
Table 26. Global Targeted Drug Market Size by Region, 2016-2026 ($ millions)
Table 27. Global Targeted Drug Market Size Share by Region, 2016-2026
Table 28. Global Platinum-based Drugs Market Size by Region, 2016-2026 ($ millions)
Table 29. Global Platinum-based Drugs Market Size Share by Region, 2016-2026
Table 30. Global Other Market Size by Region, 2016-2026 ($ millions)
Table 31. Global Other Market Size Share by Region, 2016-2026
Table 32. Cancer Medication Market Size CAGR by Application ($ millions): 2016 VS 2021 VS 2026
Table 33. Global Cancer Medication Market Size Forecast by Application, 2016-2026 ($ millions)
Table 34. Global Cancer Medication Market Size Share Forecast by Application, 2016-2026
Table 35. Blood Cancer Market Size by Region, 2016-2026 ($ millions)
Table 36. Blood Cancer Market Size Share by Region, 2016-2026
Table 37. Breast Cancer Market Size by Region, 2016-2026 ($ millions)
Table 38. Breast Cancer Market Size Share by Region, 2016-2026
Table 39. Castrointestinal Cancer Market Size by Region, 2016-2026 ($ millions)
Table 40. Castrointestinal Cancer Market Size Share by Region, 2016-2026
Table 41. Prostate Cancer Market Size by Region, 2016-2026 ($ millions)
Table 42. Prostate Cancer Market Size Share by Region, 2016-2026
Table 43. Respiratory/Lung Cancer Market Size by Region, 2016-2026 ($ millions)
Table 44. Respiratory/Lung Cancer Market Size Share by Region, 2016-2026
Table 45. Other Market Size by Region, 2016-2026 ($ millions)
Table 46. Other Market Size Share by Region, 2016-2026
Table 47. Americas Cancer Medication Market Size by Country, 2016-2021 ($ Millions)
Table 48. Americas Cancer Medication Market Size Share by Country, 2016-2021
Table 49. APAC Cancer Medication Market Size by Region, 2016-2021 ($ Millions)
Table 50. APAC Cancer Medication Market Size Share by Region, 2016-2021
Table 51. Europe Cancer Medication Market Size by Country, 2016-2021 ($ Millions)
Table 52. Europe Cancer Medication Market Size Share by Country, 2016-2021
Table 53. MENA Cancer Medication Market Size by Country, 2016-2021 ($ Millions)
Table 54. MENA Cancer Medication Market Size Share by Country, 2016-2021
Table 55. Key and Potential Regions of Cancer Medication
Table 56. Key Application and Potential Industries of Cancer Medication
Table 57. Key Challenges of Cancer Medication
Table 58. Key Trends of Cancer Medication
Table 59. Roche Details, Head Office, Cancer Medication Area Served and Its Competitors
Table 60. Roche Cancer Medication Product Offered
Table 61. Roche Cancer Medication Revenue ($ million) and YoY Growth, 2019-2021E
Table 62. Roche Main Business
Table 63. Roche Latest Developments
Table 64. HENGRUI Details, Head Office, Cancer Medication Area Served and Its Competitors
Table 65. HENGRUI Cancer Medication Product Offered
Table 66. HENGRUI Cancer Medication Revenue ($ million) and YoY Growth, 2019-2021E
Table 67. HENGRUI Main Business
Table 68. HENGRUI Latest Developments
Table 69. AstraZeneca Details, Head Office, Cancer Medication Area Served and Its Competitors
Table 70. AstraZeneca Cancer Medication Product Offered
Table 71. AstraZeneca Cancer Medication Revenue ($ million) and YoY Growth, 2019-2021E
Table 72. AstraZeneca Main Business
Table 73. AstraZeneca Latest Developments
Table 74. QILU Details, Head Office, Cancer Medication Area Served and Its Competitors
Table 75. QILU Cancer Medication Product Offered
Table 76. QILU Cancer Medication Revenue ($ million) and YoY Growth, 2019-2021E
Table 77. QILU Main Business
Table 78. QILU Latest Developments
Table 79. Sanofi Details, Head Office, Cancer Medication Area Served and Its Competitors
Table 80. Sanofi Cancer Medication Product Offered
Table 81. Sanofi Cancer Medication Revenue ($ million) and YoY Growth, 2019-2021E
Table 82. Sanofi Main Business
Table 83. Sanofi Latest Developments
Table 84. HANSOH Details, Head Office, Cancer Medication Area Served and Its Competitors
Table 85. HANSOH Cancer Medication Product Offered
Table 86. HANSOH Cancer Medication Revenue ($ million) and YoY Growth, 2019-2021E
Table 87. HANSOH Main Business
Table 88. HANSOH Latest Developments
Table 89. LUYE Details, Head Office, Cancer Medication Area Served and Its Competitors
Table 90. LUYE Cancer Medication Product Offered
Table 91. LUYE Cancer Medication Revenue ($ million) and YoY Growth, 2019-2021E
Table 92. LUYE Main Business
Table 93. LUYE Latest Developments
Table 94. Novartis Details, Head Office, Cancer Medication Area Served and Its Competitors
Table 95. Novartis Cancer Medication Product Offered
Table 96. Novartis Cancer Medication Revenue ($ million) and YoY Growth, 2019-2021E
Table 97. Novartis Main Business
Table 98. Novartis Latest Developments
Table 99. GuiZhou YiBai Details, Head Office, Cancer Medication Area Served and Its Competitors
Table 100. GuiZhou YiBai Cancer Medication Product Offered
Table 101. GuiZhou YiBai Cancer Medication Revenue ($ million) and YoY Growth, 2019-2021E
Table 102. GuiZhou YiBai Main Business
Table 103. GuiZhou YiBai Latest Developments
Table 104. Lunan Details, Head Office, Cancer Medication Area Served and Its Competitors
Table 105. Lunan Cancer Medication Product Offered
Table 106. Lunan Cancer Medication Revenue ($ million) and YoY Growth, 2019-2021E
Table 107. Lunan Main Business
Table 108. Lunan Latest Developments
Table 109. Eli Lilly and Company Details, Head Office, Cancer Medication Area Served and Its Competitors
Table 110. Eli Lilly and Company Cancer Medication Product Offered
Table 111. Eli Lilly and Company Cancer Medication Revenue ($ million) and YoY Growth, 2019-2021E
Table 112. Eli Lilly and Company Main Business
Table 113. Eli Lilly and Company Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Cancer Medication Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cancer Medication Market Size Growth Rate, 2016-2026 ($ millions)
Figure 6. Cancer Medication Consumption by Region (2016 VS 2021 & 2026) ($ millions)
Figure 7. Global Cancer Medication Market Size Share by Regions, 2016-2026
Figure 8. Americas Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 9. APAC Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 10. Europe Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 11. MENA Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 12. Global Cancer Medication Revenue Market Share by Player in 2020
Figure 13. Global Cancer Medication Market Size Share by Type in 2020
Figure 14. Cancer Medication in Blood Cancer
Figure 15. Global Cancer Medication Market Size YoY Growth: Blood Cancer, 2016-2026 ($ millions)
Figure 16. Cancer Medication in Breast Cancer
Figure 17. Global Cancer Medication Market Size YoY Growth: Breast Cancer, 2016-2026 ($ millions)
Figure 18. Cancer Medication in Castrointestinal Cancer
Figure 19. Global Cancer Medication Market Size YoY Growth: Castrointestinal Cancer, 2016-2026 ($ millions)
Figure 20. Cancer Medication in Prostate Cancer
Figure 21. Global Cancer Medication Market Size YoY Growth: Prostate Cancer, 2016-2026 ($ millions)
Figure 22. Cancer Medication in Respiratory/Lung Cancer
Figure 23. Global Cancer Medication Market Size YoY Growth: Respiratory/Lung Cancer, 2016-2026 ($ millions)
Figure 24. Cancer Medication in Other
Figure 25. Global Cancer Medication Market Size YoY Growth: Other, 2016-2026 ($ millions)
Figure 26. Americas Cancer Medication Value Market Share by Country in 2020
Figure 27. Cancer Medication Market Size in United States, 2016-2026 ($ millions)
Figure 28. Canada Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 29. Mexico Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 30. Brazil Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 31. China Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 32. Japan Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 33. Korea Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 34. Taiwan Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 35. India Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 36. Australia Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 37. Indonesia Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 38. Thailand Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 39. Malaysia Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 40. Philippines Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 41. Vietnam Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 42. Germany Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 43. France Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 44. UK Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 45. Russia Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 46. Italy Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 47. Australia Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 48. Benelux Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 49. Nordic Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 50. Saudi Arabia Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 51. UAE Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 52. Turkey Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 53. South Africa Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)
Figure 54. Egypt Cancer Medication Market Size YoY Growth, 2016-2026 ($ millions)